Large Medtronic ICD Recall; Paclitaxel PAD Devices in the Clear; Carpal Tunnel & HF

Nearly 350,000 Medtronic implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators are under Class I recall for potentially producing low-energy shocks, according to the FDA.

Another FDA alert warned that the Quidel Triage Cardiac Panel is under Class I recall for falsely low troponin test results.

However, a safety warning was found to be no longer warranted for paclitaxel-coated balloons and stents for peripheral arterial disease, the FDA announced.

The U.S. Preventive Services Task Force is maintaining its view that the evidence is insufficient to recommend routine screening of children for lipid disorders.

Dozens of gut microbiota species, including streptococci and others normally found in the mouth, were tied to coronary atherosclerosis. (Circulation)

Among ISCHEMIA study participants with chronic coronary disease, complete revascularization conferred more health status improvement than incomplete revascularization or conservative treatment. (Journal of the American College of Cardiology)

Carotid artery stenting is headed for wider reimbursement, based on a proposed National Coverage Determination from CMS.

Operators identified several predictors of successful recanalization during mechanical thrombectomy for stroke patients with M2 occlusions. (Stroke)

A complex care program for stroke survivors led to no gains in survival, but did lead to an excess of serious adverse events and falls, according to a trial from Germany. (Lancet Neurology)

BridgeBio Pharma announced positive topline results from ATTRibute-CM, a phase III study of acoramidis in transthyretin amyloid cardiomyopathy.

People with carpal tunnel syndrome were found to be more susceptible to developing heart failure within a decade. (JAMA Network Open)

As recently as 2020, only one in four heart failure patients were being referred to cardiac rehabilitation. (Circulation: Heart Failure)

Artificial intelligence was trained to identify left atrial appendage thrombus based on clinical factors and transthoracic echocardiography alone. (European Heart Journal)

In non-permanent atrial fibrillation, calcium channel blockers were associated with less bradycardia than beta-blockers, according to a subanalysis of the AFFIRM trial. (Heart)

Risk of life-threatening events after syncope may hinge on whether adrenergic or nonadrenergic triggers were involved for people with long QT syndrome. (JAMA Cardiology)

A single enteral bolus of ketone ester increased cardiac output and improved ejection fraction and glycemic control in patients with cardiogenic shock. (JACC: Heart Failure)

Researchers working on the Human Heart Cell Atlas have now mapped cells of the cardiac conduction system and launched a druggable target prediction tool. (Nature)

For small children with complete atrioventricular septal defects, staged repair with pulmonary artery banding was associated with similar survival but greater freedom from left atrioventricular valve regurgitation compared with primary repair. (Journal of Thoracic and Cardiovascular Surgery)

Does the FDA need to make more information about digital devices, such as cardiac sensors, available publicly? (JAMA Internal Medicine)

Please enable JavaScript to view the

comments powered by Disqus.